Multiple sclerosis - etiology and diagnostic potential

Joanna Kamińska1, Olga M Koper1, Kinga Piechal2

  • 1Zakład Laboratoryjnej Diagnostyki Klinicznej, Uniwersytet Medyczny w Białymstoku.

Insights

Multiple sclerosis (MS) is an autoimmune CNS disease. Diagnosis remains challenging due to varied clinical courses and the lack of a single definitive test.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic, autoimmune inflammatory and demyelinating disease affecting the central nervous system (CNS).
  • MS pathogenesis involves a complex interplay of exogenous, environmental, and genetic factors, leading to multifocal CNS damage and axonal loss.
  • Clinical presentations of MS vary, including relapsing-remitting (RRMS), secondary progressive (SPMS), primary progressive (PPMS), and progressive-relapsing (PRMS) forms, alongside benign and malignant classifications.

Purpose of the Study:

  • To review the current understanding of multiple sclerosis, encompassing its etiology, clinical classifications, and diagnostic methodologies.
  • To highlight the diagnostic challenges in MS, particularly the limitations of existing diagnostic criteria and laboratory tests.
  • To emphasize the need for improved diagnostic sensitivity and specificity for timely and accurate MS diagnosis.

Main Methods:

  • Review of established diagnostic criteria for multiple sclerosis, including the McDonald criteria.
  • Analysis of neuroimaging techniques such as magnetic resonance imaging (MRI) for identifying CNS lesions.
  • Examination of laboratory diagnostic tools, including cerebrospinal fluid (CSF) analysis (e.g., IgG index, isoelectric focusing for oligoclonal bands) and visual evoked potentials (VEPs).

Main Results:

  • MS diagnosis relies on integrating clinical findings with MRI, CSF analysis, and VEPs.
  • Cerebrospinal fluid (CSF) analysis, including Tibbling & Link IgG index, isoelectric focusing for oligoclonal bands, and reinbegrams, aids in MS diagnosis.
  • Despite advancements, MS diagnosis remains a challenge due to its diverse clinical spectrum and the absence of a single highly sensitive and specific diagnostic test.

Conclusions:

  • Multiple sclerosis is a complex autoimmune neurological disorder with varied clinical trajectories.
  • Current diagnostic approaches, while incorporating MRI and CSF analysis, still present challenges for definitive and rapid MS diagnosis.
  • Further development of diagnostic tools with enhanced sensitivity and specificity is crucial for improving the management of multiple sclerosis.